The authors present a detailed analysis of federal and state legal and regulatory protections affecting collaborative efforts to learn from patient safety data. Their discussion includes recommendations for the structure of these consortia, state privileging, and federal policy support for expanded use of consortia findings. The paper was written prior to the passage of the Patient Safety and Quality Improvement Act of 2005 (PL 109-41); this legislation should provide additional protections.